Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
355 studies found for:    diabetes and type 1 and open and active | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Device: Overnight closed-loop;   Device: Real-time CGM alone
22 Recruiting Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Intervention: Device: Closed-loop (Android Closed-Loop platform)
23 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
24 Recruiting MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin 5 mg;   Drug: Ertugliflozin 10 mg;   Drug: Glimerpiride;   Drug: Placebo to Ertugliflozin;   Drug: Placebo to Glimepiride;   Drug: Metformin;   Drug: Sitagliptin
25 Recruiting Closing the Loop 24/7 in Adolescents With Type 1 Diabetes
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Device: Closed-loop system;   Device: real-time CGM
26 Recruiting Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)
Condition: Type 1 Diabetes
Interventions: Drug: Mylan's insulin glargine;   Drug: Lantus®
27 Unknown  Health Care for Type 1 Diabetes in Developing World
Condition: Type 1 Diabetes
Interventions: Drug: basal insulin glargine;   Drug: standard therapy
28 Recruiting Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: SAR342434;   Drug: insulin lispro;   Drug: insulin glargine HOE901
29 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Metformin
30 Not yet recruiting Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care
Conditions: Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1
Intervention: Device: Paired testing of blood glucose Accu-Chek®
31 Recruiting Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Lixisenatide AVE0010;   Drug: Metformin
32 Not yet recruiting Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Condition: Treatment of Type I Diabetes Mellitus.
Intervention: Biological: Biological
33 Unknown  Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
Condition: Type 1 Diabetes
Interventions: Procedure: Isolated Pancreas Transplant;   Drug: Intensive Insulin Therapy
34 Recruiting Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Condition: Type 1 Diabetes
Interventions: Device: Closed loop with enlite sensors, insulin, liraglutide;   Device: Closed loop with enlite sensors, insulin
35 Recruiting Liraglutide and Heart Failure in Type 2 Diabetes
Conditions: Congestive Heart Failure;   Type 2 Diabetes Mellitus
Interventions: Drug: liraglutide;   Drug: glimepiride;   Drug: Metformin
36 Recruiting FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
Condition: Type 1 Diabetes
Intervention: Behavioral: FL3X: Flexible Lifestyle Empowering Change
37 Unknown  Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
Condition: Latent Autoimmune Diabetes in Adults LADA
Interventions: Drug: NovoMix 30;   Drug: Tablet treatment
38 Recruiting Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Conditions: Hypo-unawareness;   Type 1 Diabetes.
Intervention: Dietary Supplement: Medium chain triglycerides
39 Unknown  Organization Program of DiabEtes INsulIN ManaGement
Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Structured Education;   Behavioral: Conventional Diabetes Education;   Drug: Scilin®M30
40 Not yet recruiting Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years